semaglutide and greasy food Foods to Avoid on Ozempic Foods to Avoid: What

When might retatrutide become available

F.ForresterL

Figure 1: FDA Approved Incretin Mimetic (GLP-1 and dual agonist) Diabetes and Obesity Products (as of December 2023) The Future of Incretin Mimetics in Diabetes and Obesity Looking Forward GLP-1 Clinical Development Pipeline Looking Forward GLP-1 Clinical Development Pipeline While Novo Nordisk and Eli Lilly dominate todays market, the success of incretin mimetics has attracted greater interest and investment, with a slew of potential new players aiming to enter and carve out their own space

It's an FDA-approved prescription medication sold under brand names like Ozempic , Wegovy , and Rybelsus